Add like
Add dislike
Add to saved papers

Intra-abdominal cystic lymphangiomas in infancy and childhood.

BACKGROUND: Cystic lymphangiomas (CL) rarely present as intra-abdominal masses. Abdominal CL is often discussed in conjunction with mesenteric cysts; however, their histology, location and age of presentation differ significantly. In an attempt to establish a best diagnostic and treatment modality, we report our experience dealing with intra-abdominal CL during a 5-year period.

METHODS: Between January 1998 and December 2003, 12 patients, 7 boys and 5 girls, with a diagnosis of CL were reviewed. Modes of clinical presentation, location of CL, methods of diagnosis, surgical intervention and histological examination were all analyzed.

RESULTS: The ages of the 12 patients ranged from 8 days to 6 years. Eleven of the 12 patients were symptomatic with abdominal pain, abdominal distention or palpable mass , dysuria and severe acute abdominal pain mimicking appendicitis. Abdominal ultrasound was done preoperatively in all patients. At laparotomy, 5 CL were located in the omentum, 5 in the mesentery, and another 2 in the retroperitoneum. All omental CL were completely excised without difficulty. CL removal required resection of both the cyst and intestine in 2 patients. One of 2 retropritoneal CL was removed with small areas of the posterior wall of the cyst remaining on the inferior vena cava (IVC). There were no major postoperative complications, deaths, or recurrences in this series.

CONCLUSIONS: Intra-abdominal CL are usually involved in young children and are usually symptomatic. A preoperative diagnosis is possible with ultrasound study. Complete excision of the cysts with or without intestinal resection is mandatory to prevent recurrence. The long-term prognosis is excellent.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app